April 23 (Reuters) - The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined the recommended pause regarding the use of the Johnson & Johnson COVID-19 vaccine in the U.S. should be lifted and use of the vaccine should resume, the FDA said on Friday. (Reporting by Kanishka Singh in Bengaluru Editing by Chris Reese)
The Dow Jones fell as Elon Musk made a Tesla move. The Donald Trump stock sank on the stock market today. Cathie Wood bought a diving stock.
Investors rarely get a chance to buy growth stocks at such depressed valuations.
I am a dividend investor, and I prize dividend consistency. I just can't trust what this high-yield income stock says about its dividend.
David Tepper is one of the best-performing hedge fund managers.
Tesla has announced a large reduction in staff on the heels of a disappointing Q1 delivery report, following in the footsteps of legacy automakers and pure-play EV makers, per an internal memo.
You can invest along with Carl Icahn with this stock.
California fast-food employees started earning a minimum of $20 an hour in April. Thanks to a new law, which went into effect earlier this month, California chain restaurants with at least 60 locations nationwide have to pay their employees more. For smaller restaurants, the minimum wage continues to be the statewide bottom of $16 an hour. The largest publicly-traded fast-food companies include McDonald’s Corp (NYSE:MCD); Starbucks Corp (NASDAQ:SBUX); Yum! Brands, Inc. (NYSE:YUM), which owns Tac
Say that, as a married couple, you have $1.4 million in your IRAs and, at age 66, expect about $4,100 per month in Social Security. Based on some typical rules of thumb, you might be able to plan on about $108,000 per year of retirement income, but how much you actually need and will be […] The post We're 66 With $1.4 Million in IRAs, and $4,100 Monthly From Social Security. What's Our Retirement Budget? appeared first on SmartReads by SmartAsset.
Intra-Cellular Therapies stock rocketed Tuesday after its drug, Caplyta, topped expectations in a depression treatment study.
Shares of the Truth Social owner have plunged and may fall further if early investors unload shares.